Themis Medicare Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 01:11 pm
13-11-2025 | 01:11 pm
Themis Medicare's board approved Q2/H1 FY26 consolidated financial results, reporting a net loss of ₹3.62 Cr for the quarter. Key strategic moves include withdrawing the proposed merger with Gujarat Themis Biosyn and writing off investments in a dissolved UK subsidiary.
No comments yet. Be the first to comment!
